Educational Objectives

 Discuss and implement the National Cholesterol Education
 Program Adult Treatment Panel (NCEP ATP) III Guidelines.

 Explain lipoprotein metabolism and its role in the pathogenesis
 of atherosclerosis.

 Describe genetic disorders affecting lipoprotein metabolism
 and their molecular etiology.

 Outline current issues and approaches to global CV risk
 assessment.

 Manage non-lipid risk factors for dyslipidemia including
 hypertension, obesity, and cigarette smoking.

 Identify the essential features of the therapeutic lifestyle changes
 approach to reducing the risk for coronary heart disease (CHD).
 Recognize the role of drug therapy in the management of
 dyslipidemia.
 Discuss mechanism of action, phamacokinetics, side effects,
 and efficacy of pharmacological therapy.

Back to Lipidology Introduction